On ECHEMI
Home > Drugs > Shijiazhuang No.4 Pharmaceutical Co., Ltd.

Shijiazhuang No.4 Pharmaceutical Co., Ltd.

  • Founded in:

    1994-06-28
  • Country:

    China China
  • Address:

    No. 518, Huaian East Road, Shijiazhuang High-tech Industrial Development Zone
  • Tax NO.:

    911301001044060055
  • Registered Funds:

    950 million yuan
  • Website:

  • Email:

Related Drugs
Betahistine Hydrochloride and Sodium Chloride Injection
The main ingredient of this product is betahistine hydrochloride, and its chemical name is: N-methyl-2-pyridineethylamine dihydrochloride.
Name Description Content CAS NO. Registered Holders
Betastatin hydrochloride

H1 receptor agonist, has a significant dilating effect on cerebrovascular and cardiovascular systems, especially the conical artery system, significantly increases the flow of heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure; increases cochlear and vestibular blood flow, eliminates ear vertigo, tinnitus and ear closure; increases capillary permeability, promotes extracellular fluid absorption, and eliminates lymphatic edema; counteracts the vasoconstrictive effect of catecholamines and lowers arterial pressure, inhibits blood coagulation and ADP-induced platelet aggregation, and prolongs the time of thrombosis in vitro in rats; has a slight diuretic effect.

More

H1 receptor agonist, has a significant dilating effect on cerebrovascular and cardiovascular systems, especially the conical artery system, significantly increases the flow of heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure; increases cochlear and vestibular blood flow, eliminates ear vertigo, tinnitus and ear closure; increases capillary permeability, promotes extracellular fluid absorption, and eliminates lymphatic edema; counteracts the vasoconstrictive effect of catecholamines and lowers arterial pressure, inhibits blood coagulation and ADP-induced platelet aggregation, and prolongs the time of thrombosis in vitro in rats; has a slight diuretic effect.

0
Metronidazole Sodium Chloride Injection
The main ingredient of this product is: metronidazole.
Name Description Content CAS NO. Registered Holders
Metronidazole

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. Actinomycetes, Lactobacillus and Propionibacterium are resistant to it. It can also inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. It has a strong effect of killing trichomonas, and its mechanism is unknown. It is carcinogenic to some animals.

More

It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. Actinomycetes, Lactobacillus and Propionibacterium are resistant to it. It can also inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. It has a strong effect of killing trichomonas, and its mechanism is unknown. It is carcinogenic to some animals.

443-48-1 39
Compound Electrolyte Glucose MG3 Injection
This product is a compound preparation. Each 1000ml contains the following ingredients: Sodium chloride 1.75g Potassium chloride 1.50g Sodium lactate 2.24g Glucose 100g
Name Description Content CAS NO. Registered Holders
Sodium chloride

Replenish the body's necessary water and electrolytes

More

Replenish the body's necessary water and electrolytes

1.75g 7647-14-5 43
Potassium chloride

Replenish the body's necessary water and electrolytes

More

Replenish the body's necessary water and electrolytes

1.50g 7447-40-7 39
Sodium lactate

Replenish the body's necessary water and electrolytes

More

Replenish the body's necessary water and electrolytes

2.24g 312-85-6 0
GLUCOSE

The maintenance infusion is prepared with 10% glucose, and its electrolyte composition is calculated based on the average water and electrolyte requirements of the normal human body.

More

The maintenance infusion is prepared with 10% glucose, and its electrolyte composition is calculated based on the average water and electrolyte requirements of the normal human body.

100g 58367-01-4 15
Sodium Lactate Ringer's Injection
This product is a compound preparation, and its main components are: 3.10g sodium lactate, 6.00g sodium chloride, 0.30g potassium chloride, and 0.2g calcium chloride (CaCl2·2H2O) per 1000ml.
Name Description Content CAS NO. Registered Holders
Sodium lactate

The final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

More

The final metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from the blood and extracellular fluid.

3.10g 312-85-6 0
Sodium chloride

[Pharmacology and Toxicology] Under normal circumstances, there is also a small amount of lactic acid in the human blood, which is mainly generated by glucose or glycogenolysis, from muscles, skin, brain and cells, etc. After lactic acid is generated, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the terminal metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. [Pharmacokinetics] The pH of sodium lactate is 6.5-7.5. It is quickly absorbed after oral administration, oxidized by the liver within 1-2 hours, and metabolized into sodium bicarbonate, but it is generally commonly used for intravenous injection. Using sodium lactate instead of sodium acetate as a buffer for peritoneal dialysis fluid can reduce peritoneal irritation, and the effects on cardiac inhibition and peripheral vascular resistance can also be reduced.

More

[Pharmacology and Toxicology] Under normal circumstances, there is also a small amount of lactic acid in the human blood, which is mainly generated by glucose or glycogenolysis, from muscles, skin, brain and cells, etc. After lactic acid is generated, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the terminal metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. [Pharmacokinetics] The pH of sodium lactate is 6.5-7.5. It is quickly absorbed after oral administration, oxidized by the liver within 1-2 hours, and metabolized into sodium bicarbonate, but it is generally commonly used for intravenous injection. Using sodium lactate instead of sodium acetate as a buffer for peritoneal dialysis fluid can reduce peritoneal irritation, and the effects on cardiac inhibition and peripheral vascular resistance can also be reduced.

6.00g 7647-14-5 43
Potassium chloride

When hyperkalemia is accompanied by acidosis, sodium lactate can correct the acidosis and allow potassium ions to enter the cells from the blood and extracellular fluid.

More

When hyperkalemia is accompanied by acidosis, sodium lactate can correct the acidosis and allow potassium ions to enter the cells from the blood and extracellular fluid.

0.30g 7447-40-7 39
Calcium chloride

[Pharmacology and Toxicology] Under normal circumstances, there is also a small amount of lactic acid in the human blood, which is mainly generated by glucose or glycogenolysis, from muscles, skin, brain and cells, etc. After lactic acid is generated, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the terminal metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. [Pharmacokinetics] The pH of sodium lactate is 6.5-7.5. It is quickly absorbed after oral administration, oxidized by the liver within 1-2 hours, and metabolized into sodium bicarbonate, but it is generally commonly used for intravenous injection. Using sodium lactate instead of sodium acetate as a buffer for peritoneal dialysis fluid can reduce peritoneal irritation, and the effects on cardiac inhibition and peripheral vascular resistance can also be reduced.

More

[Pharmacology and Toxicology] Under normal circumstances, there is also a small amount of lactic acid in the human blood, which is mainly generated by glucose or glycogenolysis, from muscles, skin, brain and cells, etc. After lactic acid is generated, it may be converted into glycogen or acetic acid, or enter the tricarboxylic acid cycle and be decomposed into water and carbon dioxide. Therefore, the terminal metabolite of sodium lactate is sodium bicarbonate, which can correct metabolic acidosis. When hyperkalemia is accompanied by acidosis, sodium lactate can correct acidosis and allow potassium ions to enter cells from blood and extracellular fluid. The main organs that degrade lactic acid are liver and kidney. When lactic acid metabolism in the body is abnormal or impaired, the therapeutic effect is poor. [Pharmacokinetics] The pH of sodium lactate is 6.5-7.5. It is quickly absorbed after oral administration, oxidized by the liver within 1-2 hours, and metabolized into sodium bicarbonate, but it is generally commonly used for intravenous injection. Using sodium lactate instead of sodium acetate as a buffer for peritoneal dialysis fluid can reduce peritoneal irritation, and the effects on cardiac inhibition and peripheral vascular resistance can also be reduced.

0.2g 10043-52-4 29
Ambroxol Hydrochloride Orally Disintegrating Tablets
The main ingredient is ambroxol hydrochloride, and the excipients are: stearic acid, mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, sucralose, citric acid, sodium bicarbonate, sodium lauryl sulfate, sunset yellow pigment, powder flavor, and magnesium stearate.
Name Description Content CAS NO. Registered Holders
Ambroxol hydrochloride

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

More

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

23828-92-4 38
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.